<DOC>
	<DOCNO>NCT01268358</DOCNO>
	<brief_summary>This single-center , open-label , dose escalation study patient alpha-mannosidosis . 10 patient enrol study receive intravenous infusion Lamazym . In order avoid development delay hypersensitivity patient continue weekly treatment designate dose Safety Committee approve transfer rhLAMAN-03 protocol . It hypothesis Lamazym safe use .</brief_summary>
	<brief_title>Safety Study Recombinant Human Alpha-mannosidase Treatment Patients With Alpha-mannosidosis</brief_title>
	<detailed_description />
	<mesh_term>Mannosidase Deficiency Diseases</mesh_term>
	<mesh_term>alpha-Mannosidosis</mesh_term>
	<criteria>1 . The patient must confirm diagnosis alphamannosidosis define alphamannosidase activity &lt; 10 % normal activity blood leukocytes 2 . The patient must age time screen ≥ 5 year ≤ 20 year 3 . The patient must physical ability perform 6minutes walk test ( 6MWT ) , 3 minutestair climb test ( 3MSCT ) pulmonary lung function test ( spirometry , body plethysmography ) . 4 . The patient must ability mentally cooperate cognitive motor function test 5 . The patient must ability hear follow request . Hearing aid worn . 6 . Patient patient 's legally authorize guardian ( ) must provide sign , inform consent prior perform studyrelated activity ( trialrelated activity procedure would perform normal management subject ) 7 . The patient his/her guardian ( ) must ability comply protocol 1 . The patient walk without support . 2 . Presence know chromosomal abnormality syndrome affect psychomotor development , alphamannosidosis 3 . History bone marrow transplantation 4 . Presence know clinically significant cardiovascular , hepatic , pulmonary renal disease medical condition , opinion Investigator , would preclude participation trial 5 . Presence ECHO abnormality within half year , opinion Investigator , would preclude participation trial 6 . Any medical condition serious intercurrent illness , extenuate circumstance , opinion investigator , would preclude participation trial 7 . Pregnancy 8 . Psychosis within last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>